Navigation Links
ConvaTec Presents New Data on ConvaTec Moldable Technology™ and Vitala™ Continence Control Device in Ostomy Care
Date:6/7/2011

SKILLMAN, N.J., June 7, 2011 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today presented new data from multiple studies related to its advanced technologies in ostomy care including ConvaTec Moldable Technology™ and the Vitala™ Continence Control Device (CCD).  Results were presented at the Wound, Ostomy and Continence Nurses Society (WOCN) 43rd Annual Conference held June 4-8, 2011 in New Orleans, LA.

ConvaTec Moldable Technology™ Skin Barriers ConvaTec Moldable Technology™ Skin Barriers with Rebounding Memory Technology™ are the only skin barriers with a patented* tri-laminate construction that actively adjusts to the shape and contours of the stoma. ConvaTec Moldable Technology™ Skin Barriers are also backed by extensive clinical experience demonstrating their ability to prevent leaks and protect the peristomal skin.(1,2)  ConvaTec presented five abstracts on patient and heath care provider experiences with Moldable Technology™:  

  • A Survey of Quality of Life Measures in Patients Who Have Transitioned from Using a Non-Moldable Skin Barrier to a Moldable Skin Barrier (Abstract # 5452)

  • Skin Barrier Selection in an Outpatient Ostomy Clinic (Abstract # 5250)

  • The Perfect Fit: Moldable Technology in Home Care (Abstract # 5217)

  • The Road to Independence: Successful Use of Moldable Ostomy Skin Barriers to Improve Patient Outcomes (Abstract # 5137)

  • Use of a Moldable Skin Barrier with Adhesive Coupling to Manage Severely Denuded Peristomal Skin (Abstract # 5251)

  • Vitala™ Continence Control Device (CCD)Data was also presented data on the Vitala™ CCD, an innovative, non-invasive device that restores continence for up to 12 hours per day, allowing patients to manage their colostomy without having to wear a pouch or incorporate irrigation. The unique design also helps to reduce odor and noise.(3) Four prospective case studies of patient experiences with Vitala™ CCD drawn from the device's Phase 3 clinical trial(4) were presented as an abstract and poster titled:  

  • Patient and WOC Nurse Assessment of a Novel Continence Control Device (CCD): Stoma Management, Quality of Life and Productivity (Abstract # 5154)

  • "For more than 30 years, ConvaTec has been committed to meeting the needs of people living with an ostomy through breakthrough solutions in medical technology. Each of our products is developed based on health care provider and patient feedback in order to provide genuine benefits to patients and their health care teams. Our focus is on advancing technologies that can offer unparalleled security and ease of use to empower patients in their recovery from this life-changing surgery," said Brad Barton, President, ConvaTec USA.

    Vitala™ CCD is currently available in the Netherlands, Czech Republic and United Kingdom, and is soon to be launched in additional European markets.

    About ConvaTecConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.

    ConvaTec Moldable Technology, Rebounded Memory Technology and Vitala are registered trademarks of ConvaTec Inc. * U.S. Patent No. 6,840,924 B2© 2011 ConvaTec Inc.

    SC-000245-USContactsPunnie DonohueAndrea CoanConvaTec

    Berry & Company Public Relations908-904-2151

    212-253-8881Punnie.donohue@convatec.com

    acoan@berrypr.com(1) Scott V, Raasch D, Kennedy G, Heise C. Prospective assessment and classification of stoma related skin disorders. Poster presented at: 41st Annual Wound Ostomy and Continence Nurses Society Conference; June 6-10, 2009; Orlando, Florida(2) Hoeflok J, Guy D, Allen S, St-Cry D. A prospective multicenter evaluation of a moldable stoma skin barrier. Ostomy Wound Manage. 2009;55(5):62-69.(3) Multinational Phase III Vitala™ CCD 12-Hour Wear Test. CC-0196-08-A720. June 18, 2010, Data on file, ConvaTec Inc.(4) CC 0196-10-A725 Final Study Report
    '/>"/>

    SOURCE ConvaTec
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. New Data Supports ConvaTec Negative Pressure Wound Therapy
    2. ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing
    3. ConvaTec to Present at AdvaMed 2010: The MedTech Conference
    4. Bradford Barton Named President, ConvaTec U.S.
    5. ConvaTec Healthcare Announces Senior Secured Notes Offering & Senior Notes Offering
    6. ConvaTec Announces New Appointments to Leadership Team
    7. ConvaTec Announces New Appointment to Leadership Team
    8. ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans
    9. ConvaTec Healthcare Postpones Plans To Refinance Secured Term Loans
    10. Holy Family Medical Center Selects ConvaTec Negative Pressure for Wound Care
    11. ConvaTec Supported Studies to be Presented at the 24th Annual Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/24/2016)... --   , Study met ... cleansing and superiority in , Excellent ... of the ascending colon   , ... Norgine B.V. today announced new positive data from the phase III ... versus standard 2 litre PEG with ascorbate. The study met both ...
    (Date:5/24/2016)... Zealand , May 24, 2016 ... informatics solutions for the healthcare sector, has been named the ... Zealand Hi-Tech Awards 2016. Dr Bruce Davey ... acknowledgement for our team.  It,s really good to be recognised ... healthcare internationally. Our products are used in 35 countries around ...
    (Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
    Breaking Medicine Technology:
    (Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Southland ... line of classic American timber frame barn kits, which can be found on its ... inspired by historic American barn plans, and they highlight the craftsmanship of timber post ...
    (Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute stroke survivors ... sustainable product to aid in the rehabilitation process has steadily increased. Ekso Bionics had ... with hemiplegia due to stroke. , Ekso Bionics has now received clearance from the ...
    (Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated a new ... This is the first time that Coolsculpting is being used for for more than ... to ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
    (Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
    (Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
    Breaking Medicine News(10 mins):